Distinct biochemical signatures characterize peripherin isoform expression in both traumatic neuronal injury and motor neuron disease

Journal of Neurochemistry

Volumn 114, Issue 4, 2010, Pages 1177-1192

  McLean, Jesse ^a,b   Liu, Hsueh Ning ^b   Miletic, Denise ^b   Weng, Yuan Cheng ^c   Rogaeva, Ekaterina ^b   Zinman, Lorne ^d   Kriz, Jasna ^c   Robertson, Janice ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

alternative splicing; amyotrophic lateral sclerosis; inclusion; intermediate filament; sciatic crush; stroke

Indexed keywords

PERIPHERIN; TRITON X 100; BIOLOGICAL MARKER; INTERMEDIATE FILAMENT PROTEIN; ISOPROTEIN; MEMBRANE PROTEIN; NERVE PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; ELECTROPHORESIS; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MOTOR NEURON DISEASE; MOUSE; NERVE CELL LESION; NERVOUS TISSUE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BRAIN INJURIES; C57BL MOUSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; NERVE CRUSH; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROTEOMICS; SCIATIC NERVE; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOLOGICAL MARKERS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INTERMEDIATE FILAMENT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR NEURON DISEASE; NERVE CRUSH; NERVE TISSUE PROTEINS; PERIPHERINS; PROTEIN ISOFORMS; PROTEOMICS; SCIATIC NERVE;

EID: 77954736325     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06846.x     Document Type: Article

References (83)

1. Aletta J. M., Shalanski M. L. Greene L. A. (1989) Phosphorylation of the peripherin 58-kDa neuronal intermediate filament protein: regulation by nerve growth factor and other agents. J. Biol. Chem. 264, 4619 4627.
2. Alexianu M. E., Kozovska M. Appel S. H. (2001) Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57, 1282 1289.
3. Alvarez-Gago T., Bullón M. M., Rivera F., Velasco A. Mayo A. (1996) Intermediate filament aggregates in mitoses of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Histopathology 28, 349 355.
4. Anthony K. Gallo J. M. (2010) Aberrant RNA processing events in neurological disorders. Brain Res. 1338, 67 77.
5. Athlan E. S., Sacher M. G. Mushynski W. E. (1997) Associations between intermediate filament proteins expressed in cultured dorsal root ganglion neurons. J. Neurosci. Res. 47, 300 310.
6. Baudoin C., Meneguzzi G., Portier M. M., Demarchez M., Bernerd F., Pisani A. Ortonne J. P. (1993) Peripherin, a neuronal intermediate protein, is stably expressed by neuroendocrine carcinomas of the skin, their xenograft on nude mice, and the corresponding primary cultures. Cancer Res. 53, 1175 1181.
7. Beaulieu J. M., Nguyen M. D. Julien J.-P. (1999a) Late onset of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 147, 531 544.
8. Beaulieu J. M., Robertson J. Julien J.-P. (1999b) Interactions between peripherin and neurofilaments in cultured cells: disruption of peripherin assembly by the NF-M and NF-H subunits. Biochem. Cell Biol. 77, 41 45.
9. Beaulieu J. M., Kriz J. Julien J.-P. (2002) Induction of peripherin expression in subsets of brain neurons after lesion injury or cerebral ischemia. Brain Res. 16, 153 161.
10. Belayev L., Busto R., Zhao W., Fernandez G. Ginsberg M. D. (1999) Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation. Brain Res. 833, 181 190.
11. Bergeron C., Beric-Maskarel K., Muntasser S., Weyer L., Somerville M. Percy M. E. (1994) Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53, 221 230.
12. Boitard C., Villa M. C., Becourt C., Gia H. P., Huc C., Sempe P., Portier M. M. Bach J. F. (1992) Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc. Natl Acad. Sci. USA 89, 172 176.
13. Brody B. A., Ley C. A. Parysek L. M. (1989) Selective distribution of the 57 kDa neural intermediate filament protein in the rat CNS. J. Neurosci. 9, 2391 2401.
14. Brooks B. R., Miller R. G., Swash M. Munsat T. L. (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 293 299.
15. Bruijn L. I., Becher M. W., Lee M. K. et al. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327 328.
16. Buée L. Delacourte A. (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol. 9, 681 693. (Pubitemid 29470961)
17. Cairns N. J., Bigio E. H., Mackenzie I. R. et al. (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114, 5 22.
18. Carrillo J., Puertas M. C., Planas R., Pastor X., Alba A., Stratmann T., Pujol-Borrell R., Ampudia R. M., Vives-Pi M. Verdaguer J. (2008) Anti-peripherin B lymphocytes are positively selected during diabetogenesis. Mol. Immunol. 45, 3152 3162.
19. Chadan S., Moya K. L., Portier K. L. Filliatreau G. (1994) Identification of a peripherin dimer: changes during axonal development and regeneration of the rat sciatic nerve. J. Neurochem. 62, 1894 1905.
20. Collard J. F., Côté F. Julien J.-P. (1995) Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375, 61 64.
21. Corbo M. Hays A. P. (1992) Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J. Neuropathol. Exp. Neurol. 51, 531 537.
22. Corrado L., Carlomagno Y., Falasco L., Mellone S., Godi M., Cova E., Cereda C., Testa L., Mazzini L. D'Alfonso S. (2010) A novel peripherin gene (PRPH) gene mutation identified in one sporadic amyotrophic lateral sclerosis. Neurobiol. Aging doi:.
23. Côté F., Collard J. F. Julien J. P. (1993) Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73, 35 46.
24. Cui C., Stambrook P. J. Parysek L. M. (1995) Peripherin assembles into homopolymers in SW13 cells. J. Cell Sci. 108, 3279 3284.
25. Eaker E. Y. Sallustio J. E. (1994) The distribution of novel intermediate filament proteins defines subpopulations of myenteric neurons in rat intestine. Gastroenterology 107, 666 674.
26. Elder G. A., Friedrich Jr. V. L., Margita A. Lazzarini R. A. (1999) Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit. J. Cell Biol. 146, 181 192.
27. Elliott J. L. (2001) Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 95, 172 178.
28. Escurat M., Djabali K., Gumpel M., Gros F. Portier M. M. (1990) Differential expression of two neuronal intermediate-filament proteins, peripherin and the low-molecular-mass neurofilament protein (NF-L), during the development of the rat. J. Neurosci. 10, 764 784.
29. Foley J., Witte D., Chiu F. C. Parysek L. M. (1994) Expression of the neural intermediate filament proteins peripherin and neurofilament-66alpha- internexin in neuroblastoma. Lab. Invest. 71, 193 199.
30. Ganns D., Schrödl F., Neuhuber W. Brehmer A. (2006) Investigation of general and cytoskeletal markers to estimate numbers and proportions of neurons in the human intestine. Histol. Histopathol. 21, 41 51.
31. Goldman R. D., Grin B., Mendez M. G. Kuczmarski E. R. (2008) Intermediate filaments: versatile building blocks of cell structure. Curr. Opin. Cell Biol. 20, 28 34.
32. Gros-Louis F., Larivière R., Gowing G., Laurent S., Camu W., Bouchard J. P., Meininger V., Rouleau G. A. Julien J.-P. (2004) A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J. Biol. Chem. 279, 45951 45956.
33. Gurney M. E., Pu H., Chiu A. Y. et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772 1775. (Pubitemid 24227760)
34. Hall E. D., Oostveen J. A. Gurney M. E. (1998) Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23, 249 256.
35. He C. Z. Hays A. P. (2004) Expression of peripherin in ubiquinated inclusions of amyotrophic lateral sclerosis. J. Neurol. Sci. 217, 47 54.
36. Hensley K., Fedynyshyn J., Ferrell S. et al. (2003) Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol. Dis. 14, 74 80.
37. Herrmann H., Bär H., Kreplak L., Strelkov S. V. Aebi U. (2007) Intermediate filaments: from cell architecture to nanomechanics. Nat. Rev. Mol. Cell Biol. 8, 562 573.
38. Ho C. L. Liem R. K. (1996) Intermediate filaments in the nervous system: implications in cancer. Cancer Metastasis Rev. 15, 483 497.
39. Huc C., Escurat M., Djabali K., Derer M., Landon F., Gros F. Portier M. M. (1989) Phosphorylation of peripherin, an intermediate filament protein, in mouse neuroblastoma NIE 115 cell line and in sympathetic neurons. Biochem. Biophys. Res. Commun. 160, 772 779.
40. Kanitakis J., Bourchany D., Faure M. Claudy A. (1998) Expression of the intermediate filament peripherin in skin tumors. Eur. J. Dermatol. 8, 339 342.
41. Kawamata T., Akiyama H., Yamada T. McGeer P. L. (1992) Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140, 691 707.
42. Konishi H., Namikawa K., Shikata K., Kobatake Y., Tachibana T. Kiyama H. (2007) Identification of peripherin as a Akt substrate in neurons. J. Biol. Chem. 282, 23491 23499.
43. Kriz J., Meier J., Julien J.-P. Padjen A. L. (2000) Altered ionic conductances in axons of transgenic mouse expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 163, 414 421.
44. Lalancette-Hébert M., Gowing G., Simard A., Weng Y. C. Kriz J. (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596 2605.
45. Lampson L. A., Kushner P. D. Sobel R. A. (1990) Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann. Neurol. 28, 365 372.
46. Landon F., Wolff A. de Nechaud B. (2000) Mouse peripherin isoforms. Biol. Cell 92, 397 407.
47. Larivière R. C., Beaulieu J. M., Nguyen M. D. Julien J.-P. (2003) Peripherin is not a contributing factor to motor neuron disease in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase. Neurobiol. Dis. 13, 158 166.
48. Lee V. M.-Y., Goedert M. Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121 1159.
49. Leung C. L., He C. Z., Kaufmann P., Chin S. S., Naini A., Liem R. K., Mitsumoto H. Hays A. P. (2004) A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol. 14, 290 296.
50. McLean J., Xiao S., Miyazaki K. Robertson J. A. (2008) Novel peripherin isoform generated by alternative translation is required for normal filament network formation. J. Neurochem. 104, 1663 1673.
51. Migheli A., Pezzulo T., Attanasio A. Schiffer D. (1993) Peripherin immunoreactive structures in amyotrophic lateral sclerosis. Lab. Invest. 68, 185 191.
52. Oblinger M. M., Wong J. Parysek L. M. (1989) Axotomy-induced changes in the expression of a type III neuronal intermediate filament gene. J. Neurosci. 9, 3766 3775.
53. Parysek L. M. Goldman R. D. (1988) Distribution of a novel 57 kDa intermediate filament (IF) protein in the nervous system. J. Neurosci. 8, 555 563.
54. Parysek L. M., McReynolds M. A., Goldman R. D. Ley C. A. (1991) Some neural intermediate filaments contain both peripherin and the neurofilament proteins. J. Neurosci. Res. 30, 80 91.
55. Pedersen W. A., Becker L. E. Yeger H. (1993) Expression and distribution of peripherin protein in human neuroblastoma cell lines. Int. J. Cancer 53, 463 470.
56. Prasad S., Soldatenkov V. A., Srinivasarao G. Dritschilo A. (1999) Intermediate filament proteins during carcinogenesis and apoptosis. Int. J. Oncol. 14, 563 570.
57. Prieto V. G., McNutt N. S., Lugo J. Reed J. A. (1997) The intermediate filament peripherin is expressed in cutaneous melanocytic lesions. J. Cutan. Pathol. 24, 145 150.
58. Puertas M. C., Carrillo J., Pastor X. et al. (2007) Peripherin is a relevant neuroendocrine autoantigen recognized by islet-infiltrating B lymphocytes. J. Immunol. 178, 6533 6539.
59. Rhrich-Haddout F., Klosen P., Portier M. M. Horvat J. C. (1997) Expression of peripherin, NADPH-diaphorase and NOS in the adult rat neocortex. Neuroreport 20, 3313 3316.
60. Robertson J., Doroudchi M. M., Nguyen M. D., Durham H. D., Strong M. J., Shaw G., Julien J. P. Mushynski W. E. (2003) A neurotoxic peripherin splice variant in a mouse model of ALS. J. Cell Biol. 160, 939 949.
61. Rosen D. R., Siddique T., Patterson D. et al. (1993) Mutations in CuZn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59 62.
62. Rothstein J. D., Van Kammen B. A., Levey A. I., Martin L. J. Kuncl R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73 84.
63. Sarria A. J., Nordeen S. K. Evans R. M. (1990) Regulated expression of vimentin cDNA in cells in the presence and absence of a preexisting vimentin filament network. J. Cell Biol. 111, 553 565.
64. Saxena S. Caroni P. (2007) Mechanisms of axon degeneration: From development to disease. Prog. Neurobiol. 83, 174 191.
65. Schiffer D., Cordera S., Cavalla P. Migheli A. (1996) Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 139, 27 33.
66. Schweitzer S. C., Klymkowsky M. W., Bellin R. M., Robson R. M., Capetanaki Y. Evans R. M. (2001) Paranemin and the organization of desmin filament networks. J. Cell Sci. 114, 1079 1089.
67. Steinert P. M., Chou Y. H., Prahlad V., Parry D. A., Marekov L. N., Wu K. C., Jang S. I. Goldman R. D. (1999) A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin. J. Biol. Chem. 274, 9881 9890.
68. Szabolcs M. J., Visser J., Shelanski M. L., O'Toole K. Schullinger J. N. (1996) Peripherin: a novel marker for the immunohistochemical study of malformations of the enteric nervous system. Pediatr. Pathol. Lab. Med. 16, 51 70.
69. Tedeschi G., Cappelletti G., Nonnis S., Taverna F., Negri A., Ronchi C. Ronchi S. (2007) Tyrosine nitration is a novel post-translational modification occurring on the neural intermediate filament protein peripherin. Neurochem. Res. 32, 433 441.
70. Terao E., Janssens S., van den Bosch de Aguilar P., Portier M. Klosen P. (2000) In vivo expression of the intermediate filament peripherin in rat motoneurons: modulation by inhibitory and stimulatory signals. Neuroscience 101, 679 688.
71. Troy C. M., Muma N. A., Greene L. A., Price D. L. Shelanski M. L. (1990) Regulation of peripherin and neurofilament expression in regenerating rat motor neurons. Brain Res. 529, 232 238.
72. Vargas M. E. Barres B. A. (2007) Why is Wallerian degeneration in the CNS so slow? Annu. Rev. Neurosci. 30, 153 179.
73. Wang J., Xu G., Gonzales V., Coonfield M., Fromholt D., Copeland N. G., Jenkins N. A. Borchelt D. R. (2002) Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol. Dis. 10, 128 138.
74. Weng Y. C. Kriz J. (2007) Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia. Exp. Neurol. 204, 433 442.
75. Wong J. Oblinger M. M. (1990) Differential regulation of peripherin and neurofilament gene expression in regenerating rat DRG neurons. J. Neurosci. Res. 27, 332 341.
76. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W. Price D. L. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105 1116.
77. Wong N. K., He B. P. Strong M. J. (2000) Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J. Neuropathol. Exp. Neurol. 59, 972 982.
78. Xiao S., McLean J. Robertson J. (2006) Neuronal intermediate filaments and ALS: a new look at an old question. Biochim. Biophys. Acta 1762, 1001 1012.
79. Xiao S., Tjostheim S., Sanelli T., McLean J. R., Horne P., Fan Y., Ravits J., Strong M. J. Robertson J. (2008) An aggregate-inducing peripherin isoform generated through intron retention is upregulated in amyotrophic lateral sclerosis and associated with disease pathology. J. Neurosci. 28, 1833 1840.
80. Xu Z., Cork L. C., Griffin J. W. Cleveland D. W. (1993) Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73, 23 33.
81. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J., Takeuchi H., Doyu M. Sobue G. (2002) Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80, 158 167.
82. Zhu Q., Couillard-Després S. Julien J.-P. (1997) Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 148, 299 316.
83. Zinman L., Liu H. N., Sato C. et al. (2009) A mechanism for low penetrance in an ALS family with a novel SOD1 deletion. Neurology 72, 1153 1159.